Show
Sort by
-
- Miscellaneous
- open access
Bicuspid Aortic Valve in Heritable Thoracic Aortic Disease: Insights from the Montalcino Aortic Consortium
(2025) -
- Journal Article
- A1
- open access
A European Delphi consensus on the management of abdominal aortic aneurysms in patients with heritable aortic diseases
-
- Journal Article
- A1
- open access
Mitral annular disjunction in heritable thoracic aortic disease : insights from the Montalcino Aortic Consortium
-
- Journal Article
- A1
- open access
2024 ESC guidelines for the management of peripheral arterial and aortic diseases : developed by the task force on the management of peripheral arterial and aortic diseases of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN), and the European Society of Vascular Medicine (ESVM)
-
- Journal Article
- A1
- open access
HTAD patient pathway : strategy for diagnostic work-up of patients and families with (suspected) heritable thoracic aortic diseases (HTAD) : a statement from the HTAD working group of VASCERN
-
- Journal Article
- A1
- open access
Arrhythmia and impaired myocardial function in heritable thoracic aortic disease : an international retrospective cohort study
-
- Journal Article
- A1
- open access
Angiotensin receptor blockers and β blockers in Marfan syndrome : an individual patient data meta-analysis of randomised trials
-
- Journal Article
- A1
- open access
Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO
-
Genetic counselling and testing in adults with congenital heart disease : a consensus document of the ESC Working Group of Grown-Up Congenital Heart Disease, the ESC Working Group on Aorta and Peripheral Vascular Disease and the European Society of Human Genetics
-
- Journal Article
- A1
- open access
European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants